Benzinga · Jun 25, 2026
Aditxt (ADTX) Stock Sinks 20% After-Hours: Here’s What’s Going On
Aditxt stock falls after Nasdaq delisting decision suspends ADTX trading amid compliance failures.
NASDAQ · ADTX
Aditxt, Inc.
Healthcare · Biotechnology
$0.01
Down-$0.00 (-2.53%)
Updated Sep 10, 2026, 7:32 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.84K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $4.36
- Volume
- 4.81B
- Avg. volume
- 2.35M
Price performance
ADTX price history
1M range · 0 trading sessions · Daily adjusted prices
ADTX does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest ADTX news
The latest Smart Investors Daily articles mentioning ADTX.
Stock researchCompany · Overview
ADTX research
Overview
Company profile and research snapshot.
Company profile
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $160.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 6, 2023 | HC Wainwright & Co. | Buy | — |
| Nov 14, 2022 | HC Wainwright & Co. | Buy | — |
| Sep 16, 2022 | Dawson James | Neutral | — |
News briefing
No generated briefing is available yet.
Benzinga · Jun 24, 2026
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's regular session. The market value of their outstanding shares is at $22.1 million. Icecure Medical (NASDAQ:ICCM) stock
ChartMill · Jun 23, 2026
These stocks are moving in today's session
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
ChartMill · Jun 23, 2026
Tuesday's session: most active stocks
These stocks are making the most noise in today's session. Stay tuned for the latest updates!
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
